| Authors: |
Dastgerdi NK; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran., Gumus N; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk., Bayraktutan H; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk., Jackson D; School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham NG7 2RD UK., Polra K; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., McKay PF; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., Atyabi F; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran., Dinarvand R; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences Tehran Iran.; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran 1417614315 Iran., Shattock RJ; Department of Infectious Diseases, Section of Immunology of Infection, Imperial College London Norfolk Place London W21PG UK., Martinez-Pomares L; School of Life Sciences, Faculty of Medicine & Health Sciences, University of Nottingham NG7 2RD UK., Gurnani P; UCL School of Pharmacy, University College London 29-39 Brunswick Square London WC1N 1AX UK p.gurnani@ucl.ac.uk., Alexander C; Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk. |
